---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-25-002985"
form_type: "8-K"
ticker: "SLXN"
cik: "0002022416"
company_name: "Silexion Therapeutics Corp"
filed_at: "2025-08-19T23:59:59+00:00"
generated_at: "2026-05-17T11:35:54.165327+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Silexion Therapeutics shareholders approve 6x increase in authorized shares to 9M

## Summary
- Authorized capital raised from US$20,000 (1,481,482 shares) to US$121,500 (9,000,000 shares).
- Vote results: 699,871 for (59.8%), 470,828 against (40.2%), 289,225 abstentions.
- Meeting originally Aug 12, 2025, reconvened Aug 19 after no quorum; 16.8% of shares present constituted quorum under Articles.
- Memorandum Amendment filed and effective in Cayman Islands on August 19, 2025.

## SEC filing metadata
- accession: 0001178913-25-002985
- form_type: 8-K
- ticker: SLXN
- cik: 0002022416
- company_name: Silexion Therapeutics Corp
- filed_at: 2025-08-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2022416/000117891325002985/0001178913-25-002985-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2022416/000117891325002985/zk2533680.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-25-002985
- JSON: https://secwatch.observer/filing/0001178913-25-002985.json
- Plain text: https://secwatch.observer/filing/0001178913-25-002985.txt

## Key facts
- Governance Changes
  Silexion Therapeutics Corp: Increased authorized share capital via amendment to memorandum of association (effective 2025-08-19).
  - Change: charter amendment
  - Effective: 2025-08-19
  source text: the shareholders of the Company duly approved a resolution serving as an effective amendment to paragraph 5 of the Company’s amended and restated memorandum of association (the “ Memorandum Amendment”) , which increased the Company's authorized share capital
  evidence_url: https://www.sec.gov/Archives/edgar/data/2022416/000117891325002985/0001178913-25-002985-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.